(19)
(11) EP 2 021 000 A2

(12)

(88) Date of publication A3:
28.08.2008

(43) Date of publication:
11.02.2009 Bulletin 2009/07

(21) Application number: 07783549.4

(22) Date of filing: 09.05.2007
(51) International Patent Classification (IPC): 
A61K 31/40(2006.01)
A61K 31/4015(2006.01)
A61K 31/416(2006.01)
A61K 31/4184(2006.01)
A61P 25/00(2006.01)
A61K 31/4178(2006.01)
A61K 31/55(2006.01)
A61K 45/06(2006.01)
A61K 31/403(2006.01)
A61K 31/4166(2006.01)
A61K 31/505(2006.01)
A61K 31/197(2006.01)
A61K 31/44(2006.01)
(86) International application number:
PCT/US2007/068609
(87) International publication number:
WO 2007/134136 (22.11.2007 Gazette 2007/47)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
Designated Extension States:
AL BA HR MK RS

(30) Priority: 09.05.2006 US 746859 P
17.07.2006 US 807594 P
20.10.2006 US 551667

(71) Applicant: Braincells, Inc.
San Diego, CA 92121 (US)

(72) Inventors:
  • BARLOW, Carrolee
    Del Mar, CA 92014 (US)
  • CARTER, Todd, A.
    San Diego, CA 92129 (US)
  • TREUNER, Kai
    San Diego, CA 92122 (US)
  • LORRAIN, Kym, I.
    San Diego, CA 92124 (US)

(74) Representative: Roques, Sarah Elizabeth 
J.A. Kemp & Co. 14 South Square Gray's Inn
London WC1R 5JJ
London WC1R 5JJ (GB)

   


(54) NEUROGENESIS BY MODULATING ANGIOTENSIN